AAP
COGT icon

Arax Advisory Partners’s Cogent Biosciences COGT Stock Holding History

Arax Advisory Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.8K Buy
+1,287
New +$45K ﹤0.01% 3263
2026
Q1 		– Sell
-18
Closed -$639 – 3901
2025
Q4 		$639 Sell
18
-356
-95% -$10K ﹤0.01% 3565
2025
Q3 		$5.37K Buy
+374
New +$4.43K ﹤0.01% 2847
2024
Q4 		– Sell
-28
Closed -$303 – 2495
2024
Q3 		$303 Hold
28
– – ﹤0.01% 2474
2024
Q2 		$237 Buy
+28
New +$212 ﹤0.01% 2427

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arax Advisory Partners's COGT Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Cogent Biosciences (COGT) in Q2 2026: 1,287 shares worth $49.8K. The stake represents ﹤0.01% of the portfolio and ranks #3263 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in COGT as recently as Q4 2025.

Arax Advisory Partners first reported a position in COGT in Q2 2024 and has held it in 5 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Arax Advisory Partners held 1,287 shares of Cogent Biosciences worth $49.8K as of Q2 2026.
  • Cogent Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3263 holding.
  • Arax Advisory Partners first reported a position in Cogent Biosciences in Q2 2024 and has held it in 5 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.